Emerging Prospects of Exosomes for Cancer Treatment: From Conventional Therapy to Immunotherapy
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Nam, Gi-Hoon | - |
dc.contributor.author | Choi, Yoonjeong | - |
dc.contributor.author | Kim, Gi Beom | - |
dc.contributor.author | Kim, Seohyun | - |
dc.contributor.author | Kim, Seong A. | - |
dc.contributor.author | Kim, In-San | - |
dc.date.accessioned | 2021-08-30T07:06:27Z | - |
dc.date.available | 2021-08-30T07:06:27Z | - |
dc.date.created | 2021-06-18 | - |
dc.date.issued | 2020-12 | - |
dc.identifier.issn | 0935-9648 | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/51343 | - |
dc.description.abstract | Exosomes are a class of extracellular vesicles of around 100 nm in diameter that are secreted by most cells and contain various bioactive molecules reflecting their cellular origin and mediate intercellular communication. Studies of these exosomal features in tumor pathogenesis have led to the development of therapeutic and diagnostic approaches using exosomes for cancer therapy. Exosomes have many advantages for conveying therapeutic agents such as small interfering RNAs, microRNAs, membrane-associated proteins, and chemotherapeutic compounds; thus, they are considered a prime candidate as a delivery tool for cancer treatment. Since exosomes also provide an optimal microenvironment for the effective function of immunomodulatory factors, exosomes harboring bioactive molecules have been bioengineered as cancer immunotherapies that can effectively activate each stage of the cancer immunity cycle to successfully elicit cancer-specific immunity. This review discusses the advantages of exosomes for treating cancer and the challenges that must be overcome for their successful clinical development. | - |
dc.language | English | - |
dc.language.iso | en | - |
dc.publisher | WILEY-V C H VERLAG GMBH | - |
dc.subject | CELL-DERIVED EXOSOMES | - |
dc.subject | MESENCHYMAL STEM-CELLS | - |
dc.subject | IMMUNE-CHECKPOINT BLOCKADE | - |
dc.subject | BLOOD-BRAIN-BARRIER | - |
dc.subject | EXTRACELLULAR VESICLES | - |
dc.subject | DRUG-DELIVERY | - |
dc.subject | DENDRITIC CELLS | - |
dc.subject | T-CELLS | - |
dc.subject | MEDIATED ENDOCYTOSIS | - |
dc.subject | TRANSFERRIN RECEPTOR | - |
dc.title | Emerging Prospects of Exosomes for Cancer Treatment: From Conventional Therapy to Immunotherapy | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Kim, In-San | - |
dc.identifier.doi | 10.1002/adma.202002440 | - |
dc.identifier.scopusid | 2-s2.0-85092066002 | - |
dc.identifier.wosid | 000574866400001 | - |
dc.identifier.bibliographicCitation | ADVANCED MATERIALS, v.32, no.51 | - |
dc.relation.isPartOf | ADVANCED MATERIALS | - |
dc.citation.title | ADVANCED MATERIALS | - |
dc.citation.volume | 32 | - |
dc.citation.number | 51 | - |
dc.type.rims | ART | - |
dc.type.docType | Review | - |
dc.description.journalClass | 1 | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Chemistry | - |
dc.relation.journalResearchArea | Science & Technology - Other Topics | - |
dc.relation.journalResearchArea | Materials Science | - |
dc.relation.journalResearchArea | Physics | - |
dc.relation.journalWebOfScienceCategory | Chemistry, Multidisciplinary | - |
dc.relation.journalWebOfScienceCategory | Chemistry, Physical | - |
dc.relation.journalWebOfScienceCategory | Nanoscience & Nanotechnology | - |
dc.relation.journalWebOfScienceCategory | Materials Science, Multidisciplinary | - |
dc.relation.journalWebOfScienceCategory | Physics, Applied | - |
dc.relation.journalWebOfScienceCategory | Physics, Condensed Matter | - |
dc.subject.keywordPlus | CELL-DERIVED EXOSOMES | - |
dc.subject.keywordPlus | MESENCHYMAL STEM-CELLS | - |
dc.subject.keywordPlus | IMMUNE-CHECKPOINT BLOCKADE | - |
dc.subject.keywordPlus | BLOOD-BRAIN-BARRIER | - |
dc.subject.keywordPlus | EXTRACELLULAR VESICLES | - |
dc.subject.keywordPlus | DRUG-DELIVERY | - |
dc.subject.keywordPlus | DENDRITIC CELLS | - |
dc.subject.keywordPlus | T-CELLS | - |
dc.subject.keywordPlus | MEDIATED ENDOCYTOSIS | - |
dc.subject.keywordPlus | TRANSFERRIN RECEPTOR | - |
dc.subject.keywordAuthor | cancer therapeutics | - |
dc.subject.keywordAuthor | characterization and clinical-grade exosomes | - |
dc.subject.keywordAuthor | exosomes | - |
dc.subject.keywordAuthor | extracellular vesicles | - |
dc.subject.keywordAuthor | immunotherapy | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(02841) 서울특별시 성북구 안암로 14502-3290-1114
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.